Preparing Heart and Mind™: A Patient Engagement Pathway for Parents and Their Caregiving Partners After a Major Fetal Anomaly Diagnosis
1 other identifier
interventional
57
1 country
1
Brief Summary
The purpose of this study is to test and evaluate the Preparing Heart and Mind™ (PHM™) patient engagement pathway as a nurse-guided intervention to lower psychological distress and enhance caregiving competencies among mothers/birthing persons and their caregiving partners after a major fetal anomaly diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 7, 2022
CompletedFirst Posted
Study publicly available on registry
March 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedMay 1, 2023
April 1, 2023
2.3 years
February 7, 2022
April 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in State-Trait Anxiety Inventory score
State subscale, 20 items, 4-point scale; State Anxiety cut point score ≥40
12 weeks after birth
Change in Center for Epidemiology Scale-Depression (CES-D) score
20 items, 4-point scale; cut point score ≥16
12 weeks after birth
Change in Impact of Event Scale score
22 items, 4-point scale; cut point score ≥ 24
12 weeks after birth
Study Arms (2)
Intervention (PHM)
EXPERIMENTALThis pathway is intended to be a tool to enhance support for a mother/birthing person and her caregiving partner, facilitate communication with healthcare providers, and promote development of caregiving to optimize maternal-fetal, infant, and family health.
Usual Care Group (UC)
NO INTERVENTIONThe control group participants will receive care as usual.
Interventions
The technological platform referred to as Preparing Heart and Mind™ (PHM™) is designed as a patient engagement pathway. This platform includes GetWellNetwork's proprietary workflow engine, Patient Pathways™ and functionality of the Health Loop platform. Specifically, PHM™ will be created on a customized GetWellNetwork patient engagement pathway, getwell \| Loop, which is a secure platform with a parent-facing app and an interactive dashboard for healthcare providers. The PHM™ getwell \| Loop is a care program with chapters that incorporate interactive resources for patient information and education, trackers as touch points for psycho-social/educational support, and tailors care with condition-specific content, as well as action items.
Eligibility Criteria
You may qualify if:
- A study participant can include a pregnant person past 20 weeks of pregnancy (this includes a vulnerable population)
- Willing and able to comply with study procedures.
- Participants must be ≥ 18 years old.
- Participants must be able to read, write and speak English.
- Participants must have access, and ability to use a smartphone, tablet, or computer in a private location.
- The pregnant woman/person and her caregiving partner are planning for infant delivery and care.
- The fetal diagnosis of the major anomaly affects the heart (i.e., CCHD). See definition of CCHD included earlier in the protocol. Other anomalies could be present and potentially impair other organs.
- The infant's anomaly will likely require surgical and/or medical intervention within the first year of life.
- The fetus/infant is expected to live with surgical and/or medical intervention (this includes a vulnerable population).
- There may be genetic and/or chromosomal conditions in addition to the heart/structural anomalies
You may not qualify if:
- Pregnancy termination
- The fetal anomaly diagnosis is highly likely to result in fetal or infant demise shortly after birth.
- Adults lacking the capacity to consent
- Adults who do not have access to a smart phone, tablet, or device.
- Caregiving partner cannot enroll if mother is not enrolled
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne C McKechnie, PhD, RN
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2022
First Posted
March 16, 2022
Study Start
November 1, 2020
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
May 1, 2023
Record last verified: 2023-04